From the Cox Laboratory for Biomedical Engineering, Rice University, Houston, Tex (N.A.T, J.L.M., L.V.M.); the Department of Medicine, Baylor College of Medicine ...

The currently available antiplatelet drugs target key steps of platelet activation including thromboxane A 2 synthesis, ADP-mediated signaling, and glycoprotein IIb/IIIa-mediated platelet aggregation.

[59] Larger trials are necessary to confirm the existence of platelet resistance to prasugrel and to describe the possible underlining mechanisms. Elinogrel (PRT060128 or PRT128) (Figure 3 ...

Using a new type of microscope and artificial intelligence (AI), their study shows how platelet clumping can be tracked in ... People With Lupus Who Have Certain Antibodies Are More Likely to ...

Interaction between inflammatory cells and activated platelets is important in the pathogenesis of atherothrombosis and may contribute to cardiovascular risk in patients with COPD. Objectives To ...

Institute of Pharmacy, Pharmaceutical/Medicinal Chemistry and Tübingen Center for Academic Drug Discovery, Eberhard Karls University Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, Germany ...